Remission of symptomes in carcinoid syndrome with a new S-hydroxytryptamine M receptor antagonistANDERSON, J. V; COUPE, M. O; MORRIS, J. A et al.British medical journal (1857). 1987, Vol 294, Num 6580, issn 0007-1447, 1129Article

Proceedings/Antidepressant paroxetine: a specific 5-HT uptake inhibitor, international symposium, September 1988TURNER, P; WALINDER, J; DUNBAR, G. C et al.Acta psychiatrica scandinavica. Supplementum. 1989, Vol 80, Num 350, issn 0065-1591, 159 p.Conference Proceedings

Treatment of severe obsessive-compulsive disorder with fluvoxaminePRICE, L. H; GOODMAN, W. K; CHARNEY, D. S et al.The American journal of psychiatry. 1987, Vol 144, Num 8, pp 1059-1061, issn 0002-953XArticle

Pharmacologie générale du KJK-945. Effets sur le système cardiovasculaireSAKONJO, H.Yakuri to chiryo. 1988, Vol 16, Num 4, pp 233-244, issn 0386-3603Article

Clinical pharmacokinetics of ketanserinPERSSON, B; HEYKANTS, J; HEDNER, T et al.Clinical pharmacokinetics. 1991, Vol 20, Num 4, pp 263-279, issn 0312-5963, 17 p.Article

Nouveau produit : Prozac 20 mg = New drug: Prozac 20 mgJournal de psychiatrie biologique et thérapeutique. 1989, Num 34, pp 42-42, issn 0292-2509, 1 p.Article

Citalopram: étude ouverte d'un inhibiteur très sélectif du captage de la sérotonine, administré en perfusion à des patients déprimés = Citalopram. An open trial of a highly selective 5HT uptake inhibitor, administered intravenously to depressed patientsCHARBONNIER, J.-F; REBOUL, P; ROUGIER, M et al.L' Encéphale (Paris). 1987, Vol 13, Num 4, pp 249-254, issn 0013-7006Article

CYP2D6- and CYP3A-Dependent Enantioselective Plasma Concentrations of Ondansetron in Postanesthesia CareSTAMER, Ulrike M; LEE, Eun-Hae; RAUERS, Neele I et al.Anesthesia and analgesia. 2011, Vol 113, Num 1, pp 48-54, issn 0003-2999, 7 p.Article

³H-ketanserin and ³H-imipramide binding to platelets from humansOKANO, T; TOSHIMA, T; OHSUKA, Y et al.Neurosciences (Okayama). 1992, Vol 18, Num AVR, pp P37-P40, issn 0388-7448, SUPConference Paper

Symptomatic bradycardia caused by mianserin at therapeutic dosesCARCONE, B; VIAL, T; CHAILLET, N et al.Human & experimental toxicology. 1991, Vol 10, Num 5, pp 383-384Article

Treatment of chronic schizophrenia with cyproheptadine : a double-blind placebo-controlled studySILVER, H; BLACKER, M; WELLER, M. P. I et al.Biological psychiatry (1969). 1991, Vol 30, Num 5, pp 523-527, issn 0006-3223Article

Atypical antipsychotics - Recent findings and new perspectivesLOWE, J. A. III; SEEGER, T. F; VINICK, F. J et al.Medicinal research reviews (Print). 1988, Vol 8, Num 4, pp 475-497, issn 0198-6325Article

Efficacy of fluvoxamine in treatment-refractory depressionDELGADO, P. L; PRICE, L. H; CHARNEY, D. S et al.Journal of affective disorders. 1988, Vol 15, Num 1, pp 55-60, issn 0165-0327Article

Etude en double aveugle de l'efficacité d'un antisérotoninergique, le pizotifène, dans la myopathie de Duchenne de Boulogne = Double-blind study of a Serotonin antagonist, pizotifen, in Duchenne muscular dystrophySTERU, D; PACLET, J. P; THEILLAC, A et al.Archives françaises de pédiatrie. 1987, Vol 44, Num 6, pp 461-465, issn 0003-9764Article

High-performance liquid chromatography separation of ondansetron enantiomers in serum using a cellulose-derivatized stationary phase and solid-phase extractionKELLY, J. W; LANGCHONG HE; STEWART, J. T et al.Journal of chromatography. Biomedical applications. 1993, Vol 622, Num 2, pp 291-295, issn 0378-4347Article

Effects of serotonin uptake blockers and of 5-hydroxytryptophan on the voluntary consumption of ethanol, water and solid food by UChA and UChB ratsALVARADO, R; CONTRERAS, S; SEGOVIA-RIQUELME, N et al.Alcohol (Fayetteville, NY). 1990, Vol 7, Num 4, pp 315-319, issn 0741-8329, 5 p.Article

Studies on the modulation of the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitorNICHOLSON, A. N; PASCOE, P. A.Neuropharmacology. 1988, Vol 27, Num 6, pp 597-602, issn 0028-3908Article

Therapeutic efficacy of ketanserin, a selective antagonist of the serotonin (5-HT)₂ receptors, in primary and secondary Raynaud's phenomenonMELONI, F; TRANSI, M. G; SCIACCA, V et al.Angiology. 1987, Vol 38, Num 7, pp 530-536, issn 0003-3197Article

The chemistry of OndansetronMACKINNON, J. W. M; COLLIN, D. T.European journal of cancer & clinical oncology. 1989, Vol 25, pp S61-S61, issn 0277-5379, 1 p., SUP1Conference Paper

Stability of ondansetron hydrochloride injection in various beveragesWEERANUJ YAMREUDEEWONG; DANTHI, S. N; HILL, R. A et al.American journal of health-system pharmacy. 1995, Vol 52, Num 18, pp 2011-2014, issn 1079-2082Article

Soulagement symptomatique du syndrome carcinoïde par la kétansérine : une observation = Symptomatic relief of carcinoid syndrome by ketanserinLUZZATTO, G; POZZA, M; CELLA, G et al.La Presse médicale (1983). 1995, Vol 24, Num 19, pp 897-899, issn 0755-4982Article

Inhibiting effects of serotonin and serotonin antagonists on the migration of mononuclear leucocytesBONDESSON, L; NORDLIND, K; LIDEN, S et al.Immunopharmacology and immunotoxicology. 1993, Vol 15, Num 2-3, pp 243-250, issn 0892-3973Article

Effect of ketanserin on cerebral blood flow autoregulation in healthy volunteersSCHMIDT, J. F; OLSEN, K. S; WALDEMAR, G et al.Acta neurochirurgica. 1991, Vol 111, Num 3-4, pp 138-142, issn 0001-6268Article

Antiemetic efficacy and pharmacokinetic analyses of the serotonin antagonist ondansetron (GR 38032F) during multiple-day chemotherapy with cisplatin prior to autologous bone marrow transplantationLAZARUS, H. M; BRYSON, J. C; LEMON, E et al.Journal of the National Cancer Institute. 1990, Vol 80, Num 22, pp 1776-1778, issn 0027-8874Article

Arabinogalactan- and dextran-induced ear inflammation in mice: differential inhibition by H₁-antihistamines, 5-HT-serotonin antagonists and lipoxygenase blockersVAN WAUWE, J. P; GOOSSENS, J. G.Collection sécurité. 1989, Vol 28, Num 1-2, pp 78-82, issn 0538-4818Article